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Attenuation of autophagy impacts 
on muscle fibre development, 
starvation induced stress and fibre 
regeneration following acute injury
Andrea Paolini1, Saleh Omairi1, Robert Mitchell1, Danielle Vaughan1, Antonios Matsakas  2, 
Sakthivel Vaiyapuri3, Thomas Ricketts4, David C. Rubinsztein4,5 & Ketan Patel1
Autophagy has been implicated as a major factor in the development of a number of diseases of 
skeletal muscle. However, its role in skeletal muscle homeostasis is still evolving. We examined skeletal 
muscle architecture in a mouse model, Atg16L1, where autophagy is attenuated but importantly still 
present. We show that muscle fibres from Atg16L1 mice were smaller than wild-type counterparts, 
proving a role for this process in the growth of these cells. We show that mild attenuation of autophagy 
results in accelerated muscle loss during the initial phase of acute starvation. Furthermore, we show 
that regeneration of skeletal muscle following cardiotoxin (CTX) mediated injury is slower in the 
Atg16L1 mouse compared to wild-type. Lastly, we show that autophagy controls the integrity of the 
sarcolemma. Attenuated autophagy makes muscle fibres more susceptible to infiltration by circulating 
immunoglobulins following muscle injury with CTX. These fibres internalise dystrophin and nNOS. 
Importantly these fibres are able to restore dystrophin and nNOS localisation and do not die. In 
conclusion, these studies shed new light into the ability of skeletal muscle fibres to cope with injury and 
establish a link between the fine-tuning of autophagy and skeletal muscle regeneration.
Maintenance of cellular homeostasis requires robust mechanisms to remove misfolded proteins, and in the case 
of eukaryotes, aberrant organelles. Both bacteria and eukaryotes degrade proteins in a subcellular structure called 
the proteasome1. In bacteria, a signal encoded in the primary protein sequence identifies polypeptides destined 
for proteasome degradation. In contrast, eukaryotes mark proteasome substrates through poly-ubiquitination2. 
Unlike prokaryotes, eukaryotes also contain membrane bound organelles which often malfunction and need 
to be eliminated. Removal of bulk cytoplasmic content and organelles in eukaryotes is mediated by one of two 
processes called microautophagy or macroautophagy. Microautophagy is the direct engulfment of organelles 
and cytoplasm by the lysosome. In contrast macroautophagy, hereafter referred to as autophagy, involves the 
formation of a double membrane structure around the degradation target, called the autophagosome, which 
subsequently fuses with the lysosome where the final process of breakdown occurs3.
Studies on autophagy stretch back to the 1950’s with the pioneering, mainly descriptive work of de Duve4. 
However, the molecular players in this process were not characterised not until the later part of the 20th century 
and the beginning of the 21st often using yeast as a model organism. A large number of autophagy related genes 
(ATG) have been identified (to date more than 30) in this organism that participate in this process5. Autophagy 
starts with the formation of a cup-like membrane structure called the phagopore. Autophagy can be divided into 
five key stages: (1) The phagopore formation or nucleation, a process that requires VSP34 in conjunction with 
many proteins including Beclin 1 to produce PI(3)P. (2) The conjugation of multimeric Atg5-Atg12-Atg16L com-
plex to the extending phagopore, a process thought to induce curvature of the growing phagopore. (3) Processing 
and conjugation of microtubule-associated protein light chain 3 (LC3) into the phagopore. Maturation of LC3 
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requires it be lipidated through its conjugation with phosphatidylethanoalamine (PE). LC3 is proposed to be 
involved in the selection of proteins destined for autophagy6. (4) Capture of cytosol and/or organelle for degrada-
tion marked by the formation of the autophagosome (5) Fusion of autophagosome with the lysosome.
Given that autophagy is a major mechanism that controls cellular content, it is hardly surprising that its dereg-
ulation plays a significant part in the development of human diseases. Mutations in key autophagy genes have 
been identified in a spectrum of ailments ranging from cancer, neurodegenerative diseases to diseases of muscle 
(reviewed by Jiang and Mizushima7). Many human diseases have been modelled in mice through autophagy gene 
deletion or over ablation studies. Although these studies have been extremely instructive in understanding the 
role of autophagy during disease progression, they, by their robust nature, give relatively limited insights into the 
impact of this mechanism of tissue homeostasis. To achieve the later, a number of investigators have developed 
models in which autophagy is mildly increased or reduced. One such model which has proven the value of such 
an approach is the hypomorphic Atg16L1 mouse. Atg16L is a key component of autophagy. It forms a complex 
with Atg12 and Atg5 and has been shown to specify the site of LC3 lipidation of membrane biogenesis8. Cadwell 
and colleagues developed the Atg16L hypomorph mouse model called Atg16L1 in which the expression of the 
gene was diminished, but importantly not absent9. The Atg16L hypomorph mouse has decreased levels in auto-
phagy in all tissues examined to date. This mouse model was used to show that autophagy plays a role in the 
development of Crohn’s disease by controlling the activity of intestinal Paneth cells9. This mouse model has been 
extensively used to study the role of autophagy in other tissues and recently been shown to control stem cells 
developing in the brain, gut and bone10. The value of a hypomorph approach was exemplified in the later study, 
which showed that when autophagy was reduced, the outcome manifests in stem cells being maintained in an 
undifferentiated state. In contrast when key autophagy genes have been ablated this results in apoptosis of the 
neural stem cells11.
A large number of studies have investigated the role of autophagy in skeletal muscle development and its func-
tion. Most have relied on gene knock-out or over-expression strategies. These have shown that over-active or an 
absence of autophagy has a major impact on muscle mass and its ability to generate force12,13. However very few 
have examined the physiological role played by autophagy in skeletal muscle. Here we have carried out a detailed 
investigation of the skeletal muscle of the Atg16L1 mouse.
We show that autophagy plays a role in the hypertrophy of muscle fibres, allowing them to attain normal size. 
Additionally, we show that autophagy plays a significant role in coping with starvation induced stress and during 
the regeneration process following acute injury. Furthermore, we show a novel role for autophagy in maintain 
sarcolemma integrity.
Results
Autophagy and muscle fibre growth. We first established the skeletal muscle phenotype of the Atg16L1 
mouse. Atg16L1 mice were viable and were born at expected Mendelian ratios. In agreement with published 
works, the adult male Atg16L1 mice in our study weighed the same as wild-types (Fig. 1A)9. Examination of the 
weights of five hind limb muscles from Atg16L1 mice revealed that most were lighter than their wild-type coun-
terparts without reaching statistical significance (Fig. 1B). We thereafter carried out a detailed examination of a 
relatively fast contracting, glycolytic muscle, the Extensor Digitorum Longus muscle (EDL) and the soleus muscle 
a slow contracting oxidative muscle to reveal potentially subtle muscle phenotype as a consequent of reducing 
ATG16 activity. There was no significant change in either fibre number or the proportion of fibres expressing the 
major Myosin Heavy Chain isoforms (MHC) in the EDL and Soleus (Fig. 1C,D,K,L). However morphometric 
analysis revealed a small but significant decrease in the size of all MHC fibre types in both muscles (Fig. 1E,M). 
Profiling of muscle fibres based on oxidative metabolic activity, on the basis of the proportion of fibres containing 
high levels of Succinate Dehydrogenase (SDH) revealed no differences between that of Atg16L1and wild-type. 
The fibre size decrease revealed through MHC profiling was also evident when plotted against SDH activity 
(Fig. 1H,P). The numbers of capillaries associated with each muscle fibre (capillary density) was not affected 
by the Atg16L1 mutation in either muscle (Fig. 1I,Q,S–V). Lastly, we assessed oxidative stress in the Atg16L1, 
since muscle relies on high levels of metabolic activity which generates reactive oxygen species (ROS). Firstly we 
assessed the levels of ROS using Dihydroethidium (DHE)14. We found that DHE levels were elevated in the mus-
cle from Atg16L1 (Fig. 1F,N). Thereafter we quantified the levels of lipid peroxidation which is caused by ROS, by 
examining the production of 4-hydroxy-2-nonenal (4-HNE)15. We found higher levels of 4-HNE in the muscle 
from Atg16L1 compared to wild-type (Fig. 1J,R). Examination of muscle after Haematoxylin and Eosin staining 
revealed the presence of numerous aberrant fibres (with centrally located nuclei, irregular shape, extremely small 
size) originating from Atg16L1 mice which were absent in wild-type tissue (Fig. 1S–V). These results show that 
small changes in the level of autophagy results in subtle quantitative and qualitative changes in skeletal muscle 
biology.
Starvation. Autophagy has been shown to protect against nutrient stress through its ability to recycle amino 
acids to maintain viability16. We determined the impact of mildly attenuating autophagy following total nutrient 
withdrawal, by starving the two cohorts for a maximum period of 24 h. Both wild-type and Atg16L1 mutant mice 
lost body weight at both 12 h and 24 h of food deprivation (Fig. 2A). Importantly at both time points the impact 
on body weight loss was greater in Atg16L1 than wild-type (Fig. 2A). This was also the case for individual muscle 
groups at 12 h but not at 24 h of starvation, when both cohorts had lost similar levels of muscle compared to fed 
mice (Fig. 2B). All fibre types, irrespective of MHC isoform expression or expression of SDH had undergone 
atrophy in both cohorts during the starvation experiment. Importantly, during the first 12 h of starvation, atrophy 
was more pronounced in the Atg16L1 mutant mice than wild-type (Fig. 2C). However, by 24 h, both cohorts had 
similar sized fibres with respect to MHC isoform and SHD expression level classification (Fig. 2D). An almost 
identical effect of starvation was noted in the soleus muscle of Atg16L1 mutant mice compared to wild-type 
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Figure 1. Characterisation of Atg16L1 skeletal muscle from male mice. (A) Body weight. (B) Weight of hind 
limb muscles. (C) Muscle fibre count at the mid-belly of the EDL. (D) MHC profile of EDL muscle. (E) MHC 
fibre size of EDL muscle. (F) Quantification of ROS levels using DHE in the EDL muscle. (G) Profiling the 
proportion of SHD positive fibres in the EDL. (H) SDH fibre size profiling of the EDL. (I) EDL capillary density. 
(J) Quantification of lipid peroxidation using 4-HNE in the EDL. (K) Muscle fibre count at the mid-belly of 
the soleus. (L) MHC profile of soleus. (M) MHC fibre size of the soleus. (N) Quantification of ROS levels using 
DHE in the soleus. (O) Profiling the proportion of SHD positive fibres in the soleus. (P) SDH fibre size profiling 
of the soleus. (Q) Soleus capillary density. (R) Quantification of lipid peroxidation using 4-HNE in the soleus. 
(S,T) CD31 staining to identify capillaries in EDL muscle. (U,V) CD31 staining to identify capillaries in the 
soleus. (X,Y) H and E stain of EDL muscle. (Z-AA) H and E stain of soleus muscle. Centrally located nuclei 
indicated by black arrow and necrosing muscle fibre highlighted with the blue arrow in ATG16L1 muscle. Scale 
bar represents 100 µm. n = 4–6 8-week-old-male for each cohort. *p < 0.05 and **p < 0.01. Statistical analysis 
between two groups performed by two-tailed Student’s t test for independent variables.
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(Supplementary Figure 1). We examined the mechanisms underpinning the accelerated muscle loss in the first 
12 h of starvation in Atg16L1 mutant mice. Gene expression showed that the expression of Foxo3 a key regulator 
of catabolic process was induced to a greater level in Atg16L1 mutant mice than wild-type at 12 h of starvation 
(Fig. 2E). We found that key genes encoding regulators of the proteasome degradation pathway, Atrogin and 
MuRF were robustly induced in both cohorts (Fig. 2F,G). Next, we investigated, at the protein level, the abun-
dance of key regulators of muscle mass (Fig. 2H). The levels of active FoxO3a (determined by the phosphorylation 
status of Serine 320, a process mediated by kinases including Akt17) was increased by starvation in both cohorts 
(Fig. 2J). The level of activated AKT (Serine 473) as well as a downstream target (S6- Serines 240 and 244) were 
down-regulated by starvation at 12 h in both cohorts (Fig. 2K,J). The level of peIF2a a measure of ribosomal 
assembly inactivation (Serine 51) was induced by starvation only in Atg16L1 mutant mice (Fig. 2L). Expression 
of OPA1, a key molecule required to maintain mitochondrial function and subcellular localisation18 was greatly 
reduced in both cohorts by 12 h of food deprivation (Fig. 2M). However, we found that whereas there was robust 
induction of autophagy, assessed by quantifying lipidated levels of LC3, by 12 h of starvation in wild-type mice 
(Fig. 2N) there was no such outcome in Atg16L1 mutant mice (Fig. 2N). We also found that the levels of another 
autophagy protein, p62, were increased in WT after 12 hours of starvation, but not in muscle of Atg16L1 mutant 
mice (Fig. 2O). We also investigated the levels of poly-ubiquitination and found a significantly higher degree in 
the muscle of Atg16L1 mutant mice than wild-type after 12 h of starvation (Fig. 2P).
At 24 h of starvation, we detected similar elevated levels of FoxO3, Atrogin and MuRF in the two cohorts 
(Fig. 2Q,S). Western blotting showed robust increase in the levels of activated FoxO3a in both genotypes after 24 h 
of starvation (Fig. 2T,U). Western blot analysis showed that protein synthesis mediated by AKT through S6 were 
significantly inhibited in both cohorts by starvation (Fig. 2V,W). Interestingly inhibition of ribosomal assembly 
was alleviated by prolonged starvation in both cohorts (Fig. 2X). Expression of OPA1 was also different at 24 h 
compared to 12 h. Herein the levels which were previously repressed were now normal in both cohorts (Fig. 2Y). 
Nevertheless, autophagy as judged by the level of LC3 lipidation was elevated in muscle of wild-type mice after 
24 h of starvation but had not been induced even after this time in Atg16L1 mutant mice (Fig. 2Z). Levels of p62 
were similar in the muscle of both starved cohorts (Fig. 2AA). Levels of poly-ubiquitination were similar in both 
cohorts at 24 h (Fig. 2AB).
Figure 2. Accelerated muscle atrophy in Atg16L1 mice induced by starvation. (A) Body mass decrease at 12 
and 24 h after total food withdrawal. Expressed as a percentage lost compared to normally fed mice. (B) Muscle 
loss (percent of normal) following total food withdrawal. (C) Morphometric analysis of EDL fibres after 12 h 
of starvation and (D) at 24 h after food withdrawal. Changes in (E) FoxO3, (F) Atrogin and (G) MuRF1 in the 
gastrocnemius after 12 h of starvation. (H) Western blot of key proteins from the gastrocnemius after 12 h of 
starvation. Quantification of gastrocnemius protein expression for (I) pFox3a (J) pAKT, (K) pS6, (L) peIF2a, 
(M) OPA1, (N) LC3II/LCI (O) p62, and (P) levels of total poly-ubiquitination using EP8589 after 12 h of 
starvation. Changes in (O) FoxO3, (P) Atrogin and (Q) MuRF1 in the gastrocnemius after 24 h of starvation.  
(T) Western blot of key proteins from the gastrocnemius after 24 h of starvation. Quantification of gastrocnemius 
protein expression for (U) pFox3a (V) pAKT, (W) pS6, (X) peIF2a, (Y) OPA1, (Z) LC3II/LCI (AA) p62, and 
(AB) levels of total poly-ubiquitination using EP8589 after 24 h of starvation. n = 3–4 8-week-old-female for each 
cohort. *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis between two groups performed by two-tailed 
Student’s t test for independent variables.
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Muscle Regeneration. Next, we assessed the effect of small changes in the level of autophagy on muscle 
regeneration. To that end, the Tibialis Anterior muscle (TA) was damaged using cardiotoxin (CTX), a process 
known to kill muscle fibres without impacting on satellite cells, and examined at two separate time points at 
which regeneration starts (three days post-injury) and late phase of regeneration (six days post-injury)19.
There was a clear impact of genotype in terms of degeneration evidenced by the density of damaged fibres 
(assessed by the number being infiltrated by circulating Ig molecules) three days after injury. In damaged areas, 
there were five times more damaged muscle fibres in the TA of Atg16L1 compared to wild-type (Fig. 3A,B). 
The size of damaged fibres was the same between the genotypes (Fig. 3C) as was the size of regenerating fibres 
(Fig. 3D,E). Six days after muscle damage, the density of damaged fibres was still higher in the Atg16L1 albeit 
not reaching statistical significance (Fig. 3F,I). The size of damaged fibres had decreased to similar levels in both 
genotypes (Fig. 3G). However, the size of regenerating fibres was significantly smaller in the Atg16L1 compared 
to wild-type (Fig. 3H,J). We profiled the status of satellite cells and their descendants to gain an insight into the 
attenuated muscle regeneration displayed by Atg16L1 mice. Profiling of muscle stem cells (Pax7+/MyoD−), mus-
cle precursors (Pax7+/MyoD+) and committed myoblasts (Pax7−/MyoD+)20 revealed that Atg16L1 satellite cells 
were held back from differentiating, evidenced by more cells being in the stem cell state, with a deficit in numbers 
in both the precursor and in the committed myoblast state (Fig. 3K).
These results show that attenuated autophagy impacts on both the myofibre and muscle stem cells; making 
fibres more prone to infiltration after CTX administration insult and skewing the satellite cell differentiation pro-
gram towards stem cell status and away from differentiation.
Sarcolemma fragility and autophagy. During the examination of muscle following CTX injection we 
noted a major feature that segregated only with the Atg16L1 mutation. We found there was extensive infiltra-
tion of circulating Igs into fibres that appeared otherwise normal, three days after CTX injection in the muscle 
from Atg16L1 mice but not wild-type (Fig. 4A). We called this area ‘leaky’ which as otherwise stated appeared 
normal, this area had normally sized muscle fibres, the nuclei were peripherally located and there was no sign of 
cellular infiltration between fibres (see DAPI imaged in Fig. 4A). The leaky area covered the vast majority of the 
Figure 3. Attenuated regeneration of Atg16L1 skeletal muscle after acute damage. (A) Identification of muscle 
fibres infiltrated by circulating Ig in wild-type and Atg16L1 TA muscle at day 3 post injury (arrows). (B) 
Quantification of Ig infiltrated necrotic fibres, (C) necrotic fibre size and (D) size of regenerating muscle fibres 
3 days after injury. (E) Immunocytochemical image of embryonic MHC localisation to identify regenerating 
muscle fibres 3 days after injury (arrows). (F) Quantification of Ig infiltrated necrotic fibres, (G) necrotic fibre 
size and (H) size of regenerating muscle fibres 6 days after injury. (I) Identification of muscle fibres infiltrated 
by circulating Ig in wild-type and Atg16L1 TA muscle at day 6 post injury (arrows). (J) Immunocytochemical 
image of embryonic MHC localisation 6 days after injury (arrows). (K) Quantification of Pax7 and MyoD 
immunocytochemical expression in regenerating muscle at day 6 after injury. n = 3/4 8-week-old-male for each 
cohort. *p < 0.05, **p < 0.01. Statistical analysis between each two groups performed by two-tailed Student’s t 
test for independent variables.
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TA muscle from Atg16L1 mice except in three areas. The first was in the damaged region which could be readily 
identified by the significant level of cellular infiltration between damaged fibres, with the fibres in that area also 
smaller than in other regions. There were an additional two regions where fibres were of normal size and lacked 
intra-fibre Ig infiltration and inter-fibre cellular infiltration, one at a site furthest from the point of CTX injection 
(labelled ‘undamaged in Fig. 4A) and one lateral to the central TA tendon (identifiable by the auto-fluorescence in 
the wild-type image in Fig. 4A). Importantly by day six after CTX injection, the leaky area in the Atg16L1 muscle 
had been completely resolved, supported by the lack of Ig molecules inside muscle fibres (Fig. 4B).
We investigated whether the leakiness of Atg16L1 muscle fibres following exposure to CTX had an impact 
on key muscle proteins. To that end we focused on key molecules (dystrophin, nNOS and collagen IV) that 
protect muscle from contraction mediated damage and profiled their distribution in undamaged, leaky and dam-
aged regions in the two cohorts21. Dystrophin was localised to the sarcolemma in both cohorts at equal levels 
(gauged by semi-quantitative immunofluorescence) in undamaged regions (Fig. 5A–F). In damaged regions of 
both cohorts, we found that dystrophin was present but was localised to an equal extent within the muscle fibre 
(Fig. 5A,C,D,F). The most striking difference at day three with regards to dystrophin localisation between the 
two cohorts was in the leaky region; the wild-type muscle has a pattern like that of undamaged region, whereas 
corresponding region of Atg16L1 muscle showed presence of dystrophin within the muscle fibre (Fig. 5A–C). By 
day six, dystrophin localisation within the leaky area of Atg16L1 muscle had reverted to the normal sarcolemma 
position albeit at lower levels than wild-type (Fig. 5D–F). Next, we examined the impact of leaky fibres on the 
localisation of nNOS at the sarcolemma, which is totally dependent on its interaction with dystrophin22. Both 
at the qualitative and quantitative levels, we found that the distribution of nNOS mirrored that of dystrophin; 
nNOS was localised at the muscle sarcolemma in undamaged regions in both cohorts but in the fibre in damaged 
regions (Fig. 5G–I). Additionally, like dystrophin, the leaky area showed intra-fibre localisation of nNOS only in 
the Atg16L1 muscle at day three (Fig. 5G–I) which was resolved by day 6 (Fig. 5J). However, levels of nNOS at 
the sarcolemma of leaky fibres were lower in Atg16L1 muscle than wild-type (Fig. 5K,L). Lastly we examined the 
localisation and levels of a collagen IV a basal lamina component, which is bound by the dystrophin associated 
glycoprotein complex23. Compared to undamaged regions, the damaged regions at day three of either cohort 
appeared to be less uniform in terms of immunostaining signal intensity around the muscle fibre as well as in the 
thickness of the expression domain (Fig. 5M). The non-uniform and varying thickness pattern was evident in the 
leaky muscle area of Atg16L1 muscle (Fig. 5M). This feature was resolved at day 6 (Fig. 5N).
Figure 4. Sarcoplasmic fragility and autophagy. (A) Ig levels detected using immunocytochemistry three 
days after CTX injection. Damaged areas identified by the presence of small sized infiltrated fibres which also 
contain centrally located nuclei as well as huge levels of cellular infiltration. Leaky are only present at day three 
in muscle of Atg16L1 TA identified by Ig infiltration but fibres in this area are regular in shape and same size 
as in undamaged muscle. Additionally note no centrally located nuclei or cellular infiltration (A) leaky area of 
Atg16L1 muscle). (B) Infiltration of Ig in Atg16L1 muscle resolved by day six. n = 3/4 8-week-old-male for each 
cohort.
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Figure 5. The impact of attenuated autophagy following acute muscle damage on components of the 
dystrophin associated glycoprotein complex. (A) Immunocytochemical analysis of dystrophin expression in 
undamaged, leaky and damaged regions at day three. Arrows show presence of dystrophin within the fibre in 
leaky area in Agt16L1 muscle. Quantification of dystrophin levels at the sarcolemma (B) and with the fibre 
(C) with relation to muscle fibre type in three regions of interest at day three. Note all quantification levels 
compared to a baseline of 1 of undamaged type IIA fibres. (D) Immunocytochemical analysis of dystrophin 
expression in undamaged, leaky and damaged regions at day six. Quantification of dystrophin levels at the 
sarcolemma (E) and with the fibre (F) with relation to muscle fibre type in three regions of interest at day six. 
(G) Immunocytochemical analysis of nNOS expression in undamaged, leaky and damaged regions at day three. 
Arrows highlight nNOS within the fibre in leaky area in Agt16L1 muscle. Quantification of nNOS levels at the 
sarcolemma (H) and with the fibre (I) with relation to muscle fibre type in three regions of interest at day three. 
(J) Immunocytochemical analysis of nNOS expression in undamaged, leaky and damaged regions at day six. 
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Discussion
Autophagy plays two major functions in animals. Firstly, its basal activity maintain the homeostatic function of 
tissues by acting as quality control mechanism, by promoting the degradation of malfunctioning organelles and 
toxic protein aggregates3. Additionally, autophagic activity can be induced in response a variety of stress condi-
tions to act as an adaptive mechanism that underpins cell survival24. Skeletal muscle fibres rely heavily on auto-
phagy due to their cellular nature. Muscle fibres are long lived cells and being unable to divide, they cannot dilute 
the accumulation of aberrant organelles and proteins through cell division25. Additionally autophagy mobilises 
the large stores of protein in skeletal muscle, which serve as source of amino acids to support the function of other 
organs during periods of stress26,27. It is now firmly established that too much or too little autophagic activity have 
catastrophic impact on muscle function and the health of mammals12,13. However, there is a dearth of knowledge 
regarding the physiological role of autophagy on skeletal muscle structure and its responsiveness to stress and 
injury. Here, we show that mild attenuation of autophagy reveals a role for this process in skeletal muscle homeo-
stasis and ability to cope with acute nutritional and cellular stress.
Genetic diminution of autophagy by decreasing Atg16 function in mice did not impact on embryonic sur-
vival. Mice were born at expected Mendelian ratios and grew at the same rate as wild-type littermates (Fig. 1A 
and unpublished data). The skeletal muscle of Atg16L1 mice appeared on the whole normal at the histological 
level. Skeletal muscle development seems to be refractory to decreases in the level of autophagy; the tissue forms 
differentiated fibres capable of contraction even when autophagy has been completely inhibited28,29. This contrasts 
to the situation in the brain, where neurogenesis has been shown to be affected even after mild perturbation in 
autophagy as in the Atg16L1 mouse10. However, there are major differences in muscle when autophagy has been 
completely inhibited to when it is only mildly attenuated. The most striking and obvious difference is at the level 
of muscle weight. In this study we show that a decrease in autophagy manifests in a slight, albeit non-significant, 
decrease in muscle mass which contrasts starkly to the 40% decreases noted in muscle from mice where this 
activity was absent28. Nevertheless, we have been able to discern a physiological role for autophagy in muscle 
mass maintenance through the examination of fibre sub-types by showing that all fibres, categorised on MHC 
expression profile or oxidative capacity, rely on autophagy to attain their normal size. However, mild attenuation 
of autophagy had no role in the patterning of muscle fibres either on the basis of MHC profile or SDH expression. 
In agreement with the latter point, the capillary density of muscle fibres, a parameter regulated by the oxidative 
capacity of muscle fibres was not changed by a decrease in Atg16 function30. Molecular examination of skeletal 
muscle revealed that autophagy plays a major physiological role in preventing the build-up of ROS and limiting 
the harmful effects of this molecule. We show that even a mild attenuation of autophagy leads to at least a dou-
bling of the level of ROS in muscle and significant increase in the degree of lipid peroxidation. One would predict, 
based on previous studies, that although the structure of muscle from Atg16L1 mice appeared normal, that the 
build-up of ROS would have detrimental effects on muscle biology. Assessment of muscle function through the 
determination of specific force and contraction times were beyond the scope of this study but will be the focus of 
future investigations together with an ultra-structural profiling of Atg16L1 muscle for signs of organelle damage.
The importance of autophagy in regulating the functioning of muscle was truly revealed when the Atg16L1 
mice were subjected to nutritional stress and acute damage. Here we found a significant response based on gen-
otype to these insults. We show that attenuated Atg16 function led to significantly more muscle being lost in the 
first 12 h of starvation compared to wild-type mice. In both genotypes, starvation induced robust expression of 
FoxO3a a gene that encodes a master regulator of muscle atrophy through its ability to promote the expression 
of a number of L3 ubiquitin ligases including Atrogin and Murf131. Given that these factors have been induced 
in both genotypes, it is important to offer an explanation of the greater degree of muscle loss in Atg16L1 mice. 
Again, the level of protein synthesis controlled through AKT was similarly affected by starvation in both geno-
types. However, there were key differences between the genotypes when we examined the impact starvation had 
on autophagy. In agreement with previous studies, autophagy, as measured by lipidated LC3 levels, was induced 
in the muscle of wild-type mice by starvation32. In contrast there was no induction of autophagy by starvation 
in Atg16L1 mice. An important point to highlight is the presence of basal levels autophagy in fed Atg16L1 mice, 
which was not enhanced by starvation. This contrasts other studies in which key regulators of autophagy have 
been completely removed. In these studies there was no basal, let alone inducible autophagy28,29. We believe that 
the blunted response in the Atg16L1 genotype to starvation, in terms of autophagy, could be the key to increased 
levels of muscle loss identified in the first 12 h. We suggest that the absence of autophagy in the muscle of Atg16L1 
mice initiates other programmes to minimise stress and to deal with the build-up of abnormal proteins. Our data 
shows genotype-specific inhibition of eIF2α activity, a process usually controlled by the phosphorylation activity 
of PERK33. Inactivation of eIF2α not only inhibits protein synthesis as it is essential for the assembly of ribosomes 
but is also a component of the Unfolded Protein Response which becomes activated as a reaction to Endoplasmic 
Reticulum stress34. Furthermore, we show a significant increase in the degree of protein poly-ubiquitination only 
in the muscle of starved Atg16L1 mice. We propose that in the absence of a starvation inducible autophagic 
response, the muscle of Atg16L1 mice undergoes a period of accelerated muscle loss due to attenuated protein 
synthesis and high levels of poly-ubiquitin mediated polypeptide degradation. The latter two features have been 
documented in other stress related conditions, including age-related loss of mitochondrial function35. We note 
Quantification of nNOS levels at the sarcolemma (K) and with the fibre (L) with relation to muscle fibre type in 
three regions of interest at day six. Immunocytochemical analysis of Collagen IV expression at day three (M) 
and day six (N) in undamaged, leaky and damaged regions in the two cohorts. Arrows in (M) highlight non-
uniform collagen expression in Atg16L1 muscle at day three. Scale bar 100 µm. n = 3/4 8-week-old-male for 
each cohort. *p < 0.05, **p < 0.01 and ***p < 0.001. Statistical analysis between two groups performed by two-
tailed Student’s t test for independent variables.
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that by 24 h of starvation both genotypes had lost the same amount of muscle. Presently, we do not know why 
they rate of muscle loss in the Atg16L1 mice slow in the second 12 h period following starvation. However recent 
work has shown that mechanisms exist that prevent excessive muscle loss in the face of degeneration and atro-
phy and are controlled by the expression of Myostatin36. Herein it is thought that muscle loss can be mediated 
by Myostatin expression, but that it is down-regulated if it becomes excessive. In such a scenario, one would 
predict that in the first 12 h of starvation, the expression of Myostatin would be higher in Atg16L1 mice than 
WT. Thereafter, due to excessive muscle loss, its expression in Atg16L1 mice would be decreased in comparison 
to WT. However we believe that muscle loss in the WT cohort is coordinated where as in the Atg16L1 mice it is 
not. Future work will investigate the hypothesis that although the two cohorts had experienced the same degree 
of muscle loss by 24 h that deregulated atrophy in the absence of an inducible autophagic programme would have 
negatively impacted on the physiology of Atg16L1 tissue and through the assessment of Myostatin, Activin and 
GDF11 levels in the circulation.
Lastly, we show that inducible autophagy has a major impact on muscle regeneration. Our results show that 
autophagy has a role to play in the regeneration of new fibres, the clearance on dying fibres and the stability of 
muscle fibres to CTX insult. Our work shows that at day 6 after CTX injury the size of newly formed muscle fibres 
of Atg16L1 were about half the size of wild-types. We propose that the deficit in the size of newly formed muscle 
fibres could in part be due to the impact of attenuated autophagy on the activity of Satellite Cells (SC) the resident 
stem cells of skeletal muscle37,38. Satellite cells normally exist in a quiescent state with low metabolic activity39. 
They contain granules composed of translation initiation factors, RNA binding proteins and mRNA and are 
poised for activation and proliferation, a process kept in check through the inhibition of protein synthesis, medi-
ated to a large extent by the phosphorylation of eIF2α40,41. Autophagy is required for satellite cells to come out of 
their quiescent state through its ability to generate ATP needed for activation and proliferation39. Furthermore 
in the context of muscle regeneration, autophagy may also control the differentiation programme as it has been 
recently been shown that it promotes the Notch degradation, a process that would promote the development of 
committed myoblasts at the expense of stem cells10. We show that regenerating muscle from Atg16L1 mice had 
a greater proportion of muscle stem cells (Pax7+/MyoD−) and lower proportion of muscle precursors (Pax7+/
MyoD+) or committed myoblasts (Pax7−/MyoD+) than wild-type. Therefore, we postulate that the attenuated 
muscle regeneration in the Atg16L1 mice, evidenced by the smaller size of newly formed fibres (eMHC+) could 
be due to a lack of activation of stem cells after damage. This may lead to fewer myoblasts being generated to drive 
regeneration at its normal pace. These results are concordant for a role for autophagy in the differentiation of stem 
cells which has been previously described in the brain, gut and bone marrow10.
Our work also identified a novel role for autophagy in the maintenance of sarcolemma integrity. We showed 
that injection of CTX in the TA muscle of Atg16L1 mice resulted in the fibres becoming leaky and infiltrated 
by circulating Ig molecules. Although these fibres exhibited additional molecular abnormalities such as the 
intra-fibre localisation of dystrophin and nNOS, they did not die and were able to essentially restore the two 
proteins to their normal site (albeit to a lower level than normal for nNOS). CTX brings about muscle fibre death 
through the activity of Phospholipase A2 (PLA2) which binds to proteins on the sarcolemma followed by hydrol-
ysis of phospholipids42,43. Puncturing of the sarcolemma by PLA2 causes a rapid fall in the resting membrane 
potential and a rise in the cytosolic concentration of Ca2+ which activates not only proteases but also leads to 
the demise of mitochondria and ultimately fibre death44,45. The mechanism by which autophagy makes muscles 
fibres resilient to the action CTX needs to be determined but one important feature discovered by this work is 
that leaky fibres with altered sub-sarcolemma organisation (intra-fibre dystrophin and nNOS) are not necessarily 
destined to die. It is generally accepted that elevated levels of cytosolic Ca2+ are key mediators of muscle fibre 
death in muscular dystrophies or by the action of snake venoms. However the muscle fibre has a capacity to buffer 
against changes in cytosolic Ca2+ for example through the activity of mitochondria46. We propose that at sites of 
high CTX concentration, the cytosolic levels of Ca2+ cannot be buffered to prevent the activation of fibre necrosis, 
resulting in not only the death of the fibre but also infiltration by macrophages and the activation of satellite cells 
to regenerate lost tissue. However, fibres that experience a lower level of CTX become leaky but are able to buffer 
the rise in Ca2+ to levels insufficient to activate necrosis and all the other associated cellular events. Herein we 
speculate that autophagy is required to maintain membrane integrity and in its absence fibres become leaky at low 
levels of CTX which nevertheless are able to keep Ca2+ to sub-lethal levels.
In summary, our study shows that modest alteration in autophagy reveals a role for this process in muscle 
fibre growth as well as coping with starvation and acute injury. Importantly this work demonstrated the value on 
hypomorphic models of autophagy, where this process is altered slightly which may expose the physiological role 
played by this process in animals.
Methods
Mice. Healthy BL6/BC122 WT or ATG16L1 mice were bred and maintained in accordance to the Animals 
(Scientific Procedures) Act 1986 (UK) and approved by the University of Reading and University of Cambridge 
local ethics committees. The experiments were performed under a project license from the United Kingdom 
Home Office in agreement with the Animals (Scientific Procedures) Act 1986 (PPL70/7516). The University 
of Reading Animal Care and Ethical Review Committee (AWERB) approved all procedures. Animals were 
humanely sacrificed via Schedule 1 killing between 8:00–13:00. Mice were housed under standard environmental 
conditions (20–22 °C, 12–12 hr light–dark cycle) and provided food and water ad libitum. 8-week-old mice were 
used in this study.
Starvation protocol. Mice were moved from communal housing in normal cages to single housing cages 
containing a water source as well as copious inedible bedding material to mitigate any effects of hypothermia. 
Animals were monitored every 6 hours and maintained under starvation conditions for a maximum of 24 h.
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Immunohistochemistry. Dissected and frozen muscles (EDL, Soleus and TA) were mounted in Tissue 
Tech Freezing Medium (Jung) cooled by a dry ice/ethanol bath and cryosectioned at 10 µm thick sections using 
a Bright OTF cryostat (OTF/AS-001/HS) and placed onto glass slides for immunohistochemistry. Slides were 
removed from −80 °C, air dried for 30 minutes at room temperature (RT) prior to three washes in 1 × PBS. 
Muscle sections were incubated in permeabilisation buffer solution (0.952 g Hepes, 0.260 g MgCl2, 0.584 g NaCl, 
0.1 g Sodium azide, 20.54 g Sucrose and 1 ml Triton X-100 in 200 ml dH2O) for 15 minutes at room temperature. 
To remove excess permeabilisation buffer, another three five minutes washes in 1 × PBS were performed before 
the application of block wash buffer (PBS with 5% foetal calf serum (v/v), 0.05% Triton X-100) for 30 minutes at 
room temperature.
Primary antibodies were pre-blocked in wash buffer for 30 minutes prior to application onto muscle sections 
overnight at 4 °C. In order to remove the primary antibodies, muscle sections were washed three times in wash 
buffer with each wash lasting 10 minutes. Primary antibodies were identified using Alexa flour 488, 594 and 633 
secondary antibodies. All secondary antibodies were pre-blocked in wash buffer for minimum of 30 minutes 
prior to their application onto the slides (1 hr in the dark at room temperature). Thereafter the muscle sections 
were washed three-10 minutes washes in PBS to remove the secondary antibody. Finally, slides were mounted in 
fluorescent mounting medium, and myonuclei were visualized using (2.5 μg/ml) 4,6-diamidino-2-phenylindole 
(DAPI). Details of primary and secondary antibodies are given in Supplementary Data File 1.
Succinate dehydrogenase (SDH) staining. Muscle sections were incubated for 3–5 minutes at room 
temperature in a sodium phosphate buffer containing 75 mM sodium succinate (Sigma), 1.1 mM Nitroblue 
Tetrazolium (Sigma) and 1.03 mM Phenazine Methosulphate (Sigma). Samples were then fixed in 10% 
formal-calcium and cleared in xylene prior to mounting with DPX mounting medium (Fisher). Densitometry of 
the samples was performed on a Zeiss Axioskop2 microscope mounted with an Axiocam HRc camera. Axiovision 
Rel. 4.8 software was used to capture the images.
Dihydroethidium (DHE) and 4-hydroxy-2-nonenal (4-HNE) staining. Muscle sections were rehy-
drated in 1 × PBS for 5 minutes before being incubated with 10 µM of DHE (Sigma-Aldrich 7008) 30 minutes at 
37 °C or 4-HNE antibody. The slides were then washed in 1 × PBS three times with each wash lasting 5 minutes. 
Finally, slides were mounted in fluorescent mounting medium, and myonuclei were visualised using (2.5 µg/ml) 
4,6-diamidino-2-phenylindole (DAPI).
Quantitative PCR. Frozen Gastrocnemius muscles were cut into three thirds, and (40–50 mg) pieces of 
each muscle pulverised and solubilised in TRIzol® (Fisher) using a tissue homogenizer (QIAGEN). Total RNA 
was isolated and purified using the RNesay Mini Kit (Quigen, Manchester, UK, 74104). RNA concentrations 
were measured using the Nanodrop 2000 (Thermo Scientific). RNA (5 μg) was reverse-transcribed to cDNA with 
SuperScript II Reverse Transcriptse (Invitrogen) and analysed by quantitative real-time RT-PCR on a StepOne 
Plus cycler, using the Applied Biosystems SYBR-Green PCR Master Mix. Primers were designed using the soft-
ware Primer Express 3.0 (Applied Biosystems). Relative expression was calculated using the ΔΔCt method with 
normalization to the housekeeping genes cyclophilin-B and hypoxanthine-guanine phosphoribosyltransferase 
(HPRT). Specific primer sequences are given in Supplementary Data File.
Capillary density quantification. Muscles sections (EDL and Soleus) were immunostained using CD31 
antibody in order to identify the number of blood vessels that serve each muscle fibre. Quantification of capillary 
density was performed by selecting central area of muscle sections that includes approximately 150 to 200 fibres 
The number of muscle fibres were determined as well as the number of CD31+ in the selected area. Thereafter the 
ratio of blood capillaries to fibres (C:F) was calculated.
Antigen retrieval immunostaining for Pax7/MyoD quantification. In order to quantify posi-
tive Pax7 and MyoD cells and to improve the presentation of our target antigens and enhance immunoreac-
tivity, pre-treatment with the antigen retrieval reagents was performed. Sectioned slides were fixed in 4% PFA 
for 20 minutes at RT and incubated in 100% methanol for 5 minutes before being immersed into the preheated 
retrieval solution for 2–10 minutes. Following the incubation, three five minutes washes in 1 × PBS were per-
formed to remove excess retrieval solution from the slides. Sectioned slides were then pre-blocked in wash buffer 
for 30 minutes at room temperature before being incubated with primary antibodies (Pax7 and MyoD) overnight 
at 4 °C. Primary antibodies were identified using anti- mouse or anti rabbit Alexa fluor 488, 594 and 633 second-
ary antibodies. Steps of day 2 of immunostaining protocol were followed before slides being mounted in fluores-
cent mounting medium and coverslip was placed over the top.
Quantification of positive Pax7 and MyoD cells was performed by counting nuclei in the damaged areas of TA 
muscles, then counting the number of Pax7+ expressing cells or MyoD+ expressing cells or cells that expressed 
bothPax7+/MyoD+. Example of Pax7/MyoD stating is given in Supplementary figure X. A positive signal was 
only noted where the expression of either epitope co-localised to a DAPI stained nuclei. Data is presented as the 
number of events per square millimetre of damaged muscle. Example of Pax7 and MyoD immunohistochemistry 
of damaged muscle is given in Supplementary Figure 2.
Western blotting. Frozen gastrocnemius muscles were powdered and lysed in a buffer containing 4 M Urea, 
125 mM Tris pH 6.8, 4% SDS and protease inhibitor cocktail set 1 (calbiochem). Protein concentration was deter-
mined via Bradford Assay (BioRad). 30 µg protein for each sample was resolved on a 4–12% SDS page gel (Life 
Technologies) prior to 3 hour transfer at 30 V on to a PVDF membrane (Thermo Scientific) for immunoblot-
ting (details of antibodies used are given in supplementary information file). Blots were visualised with ECL™ 
www.nature.com/scientificreports/
1 1SCIentIfIC RePoRts |  (2018) 8:9062  | DOI:10.1038/s41598-018-27429-7
Prime Western Blotting System (GE Healthcare). Images of Western blots were taken using ImageQuant LAS 
4000 mini, ensuring they were below signal saturation. Protein expression was quantified using Fiji software and 
normalised to the expression of housekeeping proteins.We followed the journals guidelines for the presentation 
of Western blot data. All antibodies were initially characterised so that blotting conditions gave unequivocal 
recognition of the correct epitope, wherein entire blotting membrane was used. Examples of such blots are given 
in Supplementary Figure 3. Thereafter after blotting, membranes were sometimes cuts (guided by the molecular 
weight of a particular epitope and processed with different antibodies. This practice maximised the data return 
for a given amount of biological sample. Presentation of individual bands sometimes required cropping for purely 
repositioning purposes and was used for clarity and presentational purposes alone.
Semi-quantitative Measures of Sarcolemma Protein Expression. Intensity of signals from the protein 
of interest was measured as previously described47,48. Briefly, membrane signal intensities of approximately 30 mus-
cle fibres of each MHC phenotype (IIA and IIB) in all muscle sections from wild type and Atg16L1 were analyzed. 
Images of muscle sections after immunostaining were firstly captured using Zeiss AxioImager A1, then tiles assem-
bled into whole muscle image using Photoshop CS3 as JPEG files. Fiji software was used to measure the signal from 
the JPEG pictures of the area of interest after images had been corrected for background to avoid signal saturation. 
To calculate relative signal intensity levels, individual measurements from treated and control fibres were taken as a 
percentage of mean of control samples. The same process was used for DHE and 4-HNE quantification.
Imaging and analysis. Zeiss AxioImager A1 microscope was used to examine immunofluorescent stained 
sections, and images were captured using an Axiocam digital camera with Zeiss Axiovision computer software 
version 4.8.
Statistical Analysis. Data are presented as mean ± SE. Significant differences between two groups were 
performed by two-tailed Student’s t test for independent variables. Differences among groups were analyzed by 
two-way ANOVA followed by Bonferroni multiple comparison tests as appropriate. Statistical analysis was per-
formed on GraphPad Prism software. Differences were considered statistically significant at *p < 0.05, **p < 0.01, 
or ***p < 0.001.
Data availability. All relevant data related to this manuscript are available from the authors upon reasonable 
request.
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